Alaunos Therapeutics (TCRT) Competitors $4.54 +0.32 (+7.58%) As of 11:14 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TCRT vs. TSBX, SLXN, MYNZ, RLMD, ABVC, PHIO, CHRO, GLTO, DWTX, and AIMDShould you be buying Alaunos Therapeutics stock or one of its competitors? The main competitors of Alaunos Therapeutics include Turnstone Biologics (TSBX), Silexion Therapeutics (SLXN), Mainz Biomed (MYNZ), Relmada Therapeutics (RLMD), ABVC BioPharma (ABVC), Phio Pharmaceuticals (PHIO), Chromocell Therapeutics (CHRO), Galecto (GLTO), Dogwood Therapeutics (DWTX), and Ainos (AIMD). These companies are all part of the "pharmaceutical products" industry. Alaunos Therapeutics vs. Turnstone Biologics Silexion Therapeutics Mainz Biomed Relmada Therapeutics ABVC BioPharma Phio Pharmaceuticals Chromocell Therapeutics Galecto Dogwood Therapeutics Ainos Alaunos Therapeutics (NASDAQ:TCRT) and Turnstone Biologics (NASDAQ:TSBX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Do institutionals and insiders believe in TCRT or TSBX? 27.7% of Alaunos Therapeutics shares are held by institutional investors. Comparatively, 52.5% of Turnstone Biologics shares are held by institutional investors. 5.1% of Alaunos Therapeutics shares are held by company insiders. Comparatively, 32.1% of Turnstone Biologics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is TCRT or TSBX more profitable? Turnstone Biologics' return on equity of -105.99% beat Alaunos Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Alaunos TherapeuticsN/A -267.77% -209.18% Turnstone Biologics N/A -105.99%-87.27% Which has higher valuation & earnings, TCRT or TSBX? Alaunos Therapeutics has higher earnings, but lower revenue than Turnstone Biologics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlaunos Therapeutics$7K965.17-$35.14MN/AN/ATurnstone Biologics$19.31M0.45-$55.20M-$3.24-0.12 Which has more risk & volatility, TCRT or TSBX? Alaunos Therapeutics has a beta of -0.53, suggesting that its share price is 153% less volatile than the S&P 500. Comparatively, Turnstone Biologics has a beta of 2.04, suggesting that its share price is 104% more volatile than the S&P 500. Does the media prefer TCRT or TSBX? In the previous week, Turnstone Biologics had 7 more articles in the media than Alaunos Therapeutics. MarketBeat recorded 9 mentions for Turnstone Biologics and 2 mentions for Alaunos Therapeutics. Alaunos Therapeutics' average media sentiment score of 0.50 beat Turnstone Biologics' score of 0.33 indicating that Alaunos Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alaunos Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Turnstone Biologics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community believe in TCRT or TSBX? Alaunos Therapeutics received 3 more outperform votes than Turnstone Biologics when rated by MarketBeat users. Likewise, 58.33% of users gave Alaunos Therapeutics an outperform vote while only 44.44% of users gave Turnstone Biologics an outperform vote. CompanyUnderperformOutperformAlaunos TherapeuticsOutperform Votes758.33% Underperform Votes541.67% Turnstone BiologicsOutperform Votes444.44% Underperform Votes555.56% Do analysts recommend TCRT or TSBX? Turnstone Biologics has a consensus target price of $0.45, suggesting a potential upside of 19.36%. Given Turnstone Biologics' stronger consensus rating and higher probable upside, analysts clearly believe Turnstone Biologics is more favorable than Alaunos Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alaunos Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Turnstone Biologics 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 SummaryTurnstone Biologics beats Alaunos Therapeutics on 9 of the 14 factors compared between the two stocks. Remove Ads Get Alaunos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TCRT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCRT vs. The Competition Export to ExcelMetricAlaunos TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.76M$6.73B$5.54B$7.49BDividend YieldN/A2.79%4.86%4.04%P/E RatioN/A6.9923.2518.07Price / Sales965.17198.60361.2586.83Price / CashN/A65.6738.1634.64Price / Book1.075.926.493.99Net Income-$35.14M$142.37M$3.21B$247.18M7 Day Performance189.04%-7.24%-4.89%-4.25%1 Month Performance183.22%-10.45%-0.07%-6.87%1 Year Performance-76.29%-14.58%6.41%-3.73% Alaunos Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCRTAlaunos Therapeutics0.8131 of 5 stars$4.54+7.6%N/A-76.8%$7.02M$7,000.000.0040Upcoming EarningsShort Interest ↓Gap UpHigh Trading VolumeTSBXTurnstone Biologics1.8495 of 5 stars$0.41-0.2%$0.45+10.0%-87.1%$9.46M$19.31M-0.1382Earnings ReportAnalyst RevisionNews CoverageSLXNSilexion TherapeuticsN/A$1.12-1.8%$5.00+346.4%N/A$9.43MN/A0.00N/AGap UpMYNZMainz Biomed1.9462 of 5 stars$4.62+0.9%$14.00+203.0%-92.4%$9.25M$917,203.00-0.0730Upcoming EarningsGap UpRLMDRelmada Therapeutics3.8804 of 5 stars$0.30+1.9%$4.25+1,307.3%-94.1%$9.11MN/A-0.1110ABVCABVC BioPharma1.302 of 5 stars$0.70+1.2%N/A-29.1%$9.06M$509,788.00-0.8130News CoveragePositive NewsPHIOPhio Pharmaceuticals1.9257 of 5 stars$1.30+0.8%$4.00+207.7%-81.4%$8.95MN/A-0.1210Upcoming EarningsNews CoverageGap UpCHROChromocell TherapeuticsN/A$1.48-5.7%N/A-47.3%$8.92MN/A0.004Gap DownGLTOGalecto2.2324 of 5 stars$6.70+9.8%$10.00+49.3%-84.6%$8.82MN/A-0.3540News CoverageGap UpHigh Trading VolumeDWTXDogwood TherapeuticsN/A$6.47+2.2%N/AN/A$8.62MN/A-0.995Earnings ReportNews CoverageGap UpAIMDAinos0.6688 of 5 stars$0.54+1.7%N/A-53.8%$8.32M$20,729.00-0.3340 Remove Ads Related Companies and Tools Related Companies Turnstone Biologics Alternatives Silexion Therapeutics Alternatives Mainz Biomed Alternatives Relmada Therapeutics Alternatives ABVC BioPharma Alternatives Phio Pharmaceuticals Alternatives Chromocell Therapeutics Alternatives Galecto Alternatives Dogwood Therapeutics Alternatives Ainos Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TCRT) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alaunos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TCRT Stock Free TCRT Stock Alerts